In this Q&A, Brittany A. Davidson, MD, discusses navigating goals-of-care conversations in gynecologic oncology, including how to identify patients at high risk of death who might benefit from a timely...
In this interview, Elmar Joura, MD, answers questions about the long-term follow-up data on sustained immunogenicity and safety for the 9-valent human papillomavirus (HPV) vaccine, including indications,...
In this interview, Jacob C. Jentzer, MD, assistant professor of medicine in the Department of Cardiovascular Medicine at the Mayo Clinic in Rochester, Minnesota discusses the implications of his study and...
Stephanie Blank, MD, answers questions about the session she hosted at The Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women's Cancer titled “The Future is Now: Determining the Fate of...
Yuriko Fukuta, MD, PhD, discusses her research team's study, which evaluated the risk factors associated with post-COVID conditions. She presented her findings at IDWeek 2023 in Boston, MA.
Acetylcholinesterase inhibitors are frequently used in the treatment of Alzheimer disease due to their anti-inflammatory effects. But what is the potential of this class of medications to also impact the...
Jennifer Walsh, DNP, CPNP, CNE talks about the reasons for the sudden surge in measles cases in the United States, what clinicians can do to make their patients aware of the increase, and the potential...
In this Q and A, Chief Investigator of the EMPA-KIDNEY trial, William Herrington, MA, MBBS, MD, answers questions about the results of the trial, including the effects of the SGLT2 inhibitor, empagliflozin,...
In this expert Q&A, lead study author Hyon K. Choi, MD, DrPH, discusses his team's study examining the association between serum urate levels and the rate of recurrent gout flares among patients with a...
In this expert interview, Melissa E. Badowski, PharmD, MPH, provides an overview of her presentation at IDWeek 2023 titled, "Guideline Adherence to Hepatitis B Virus Screening and Vaccination in Patients...